Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Starts 2015 As It Plans To Go On: A Spate Of Approvals, A Full Slate Of Possibilities

Feb 25 2015

• By Bridget Silverman

Related Content

Spotlight Returns To Biogen R&D To Sustain Success

Feb 02 2015

Franchise Management Likely To Be Theme Of 2015 Oncology Approvals

Feb 25 2015

Related Companies

Novartis AG

Novartis AG

Pfizer Inc.

Johnson & Johnson

Pharmacyclics, Inc.

Genentech, Inc.

Takeda Pharmaceutical Co. Ltd.

AbbVie Inc.

Amneal Pharmaceuticals, Inc.

Symplmed Pharmaceuticals LLC

Boehringer Ingelheim GmbH

Eli Lilly and Company

Bristol Myers Squibb Company

Merck & Co., Inc.

Rockwell Medical Inc.

Synageva BioPharma Corp.

Alexion Pharmaceuticals Inc.

Vertex Pharmaceuticals Incorporated

Prosensa Holding N.V

BioMarin Pharmaceutical Inc.

PTC Therapeutics, Inc.

Sarepta Therapeutics, Inc.

Acadia Pharmaceuticals Inc.

Roche Holding AG

Gilead Sciences, Inc.

InterMune, Inc.

Allergan plc

Amgen, Inc.

Celltrion, Inc.

Apotex Inc.

Intas Pharmaceuticals Ltd.

Hospira, Inc.

Biogen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

GSK plc

Additional Topics

Regulation Approvals BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window